Korea’s CHA Healthcare takes a controlling stake in Singapore Medical Group, the private specialist healthcare provider, providing funds for further mergers and acquisitions.
“We are very excited by the partnership of both groups,” said Robert Allen, CHS global chief executive officer “CHS has a strong reputation for world-class fertility treatments, pioneering many of the cutting-edge advances in reproductive medicine. This partnership will further strengthen our position as a global benchmark for premium healthcare services, and we see many opportunities to create synergies between the various continents to provide an exceptional patient experience.”
CHA Healthcare, the international healthcare investment and management arm of the CHA Group, is one of the largest and most diversified private healthcare service groups in Asia and operates 26 general hospitals and medical centres in six countries.
Singapore Medical Group’s growth has most recently been in in obstetrics and gynaecology, paediatrics, diagnostics and aesthetics.
©2024 All rights reserved LaingBuisson 
